首页> 外文期刊>BMC Pulmonary Medicine >Haemoptysis as the first presentation of COVID-19: a case report
【24h】

Haemoptysis as the first presentation of COVID-19: a case report

机译:血液术称为Covid-19的第一次演示:案例报告

获取原文
           

摘要

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that profoundly challenges healthcare systems all over the world. Fever, cough and fatigue are the most commonly reported clinical symptoms. A 58-year-old man presented at the emergency department with acute onset haemoptysis. On the fifth day after admission, he developed massive haemoptysis. Computed tomography (CT) angiography of the chest revealed alveolar haemorrhage, more prominent in the left lung. Flexible bronchoscopy confirmed bleeding from the left upper lobe, confirmed by a bronchial arteriography, which was successfully embolized. Nasopharyngeal swabs (NPS) tested for SARS-CoV-2 using real-time polymerase chain reaction (RT-PCR) repeatedly returned negative. Surprisingly, SARS-CoV-2 was eventually detected in bronchoalveolar lavage (BAL) fluid. Life-threatening haemoptysis is an unusual presentation of COVID-19, reflecting alveolar bleeding as a rare but possible complication. This case emphasises the added value of bronchoscopy with BAL in the diagnostic work-up in case of high clinical suspicion and negative serial NPS in patients presenting with severe symptoms.
机译:由严重的急性呼吸综合征冠状病毒2(SARS-COV-2)引起的冠状病毒疾病2019(Covid-19)是一个持续的大流行,这是一个深刻的挑战世界各地的医疗保健系统。发烧,咳嗽和疲劳是最常见的临床症状。一名58岁男子患有急性发病血症粪便疗效。在入学后第五天,他开发了大量的粪便。计算断层扫描(CT)胸部的血管造影显示肺泡出血,在左肺中更加突出。柔性支气管镜检查通过支气管动脉造影证实,通过支气管动脉造影证实,确认了左上角的渗出。使用实时聚合酶链反应(RT-PCR)对SARS-COV-2测试的鼻咽拭子(NPS)反复返回阴性。令人惊讶的是,SARS-COV-2最终在支气管肺泡灌洗(BAL)液中检测到。危及生命的血液粪便是Covid-19的不寻常呈现,反映肺泡出血作为罕见但可能的并发症。这种情况强调支气管镜检查的额外值与BAL在患有严重症状的患者中高临床怀疑和负系列NPS的诊断后处理。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号